Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSA-GCSF for Chemotherapy-induced Neutropenia in Breast Cancer
NCT02465801Phase 2Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rHSA-GCSF in chemotherapy-induced neutropenia (CIN), sponsored by CanSino Biologics Inc.. Started Dec 2014; status: completed.
02
Drugs
rHSA-GCSF
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT02465801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465801.